Skip to content

Rationale for the use of CytoSorb in COVID-19 patients

7th International CytoSorb Users` Meeting | 2020 | Berlin

  • Welcome | Stefan Baudis & Christian Steiner
  • The Rotterdam study – long term outcome in septic shock patients | Can Ince
  • Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski
  • The International CytoSorb Registry | Frank Brunkhorst
  • The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann
  • Liver support on a higher level – what we already know | Mihai Popescu
  • The right anticoagulation – we have a lot of options | Gilda Cinnella
  • Update on drug removal – more pros than cons | Steffen Mitzner
  • Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus
  • Experiences from Italy | Giorgio Berlot
  • Experiences from Iran | Amir Ahmad Nassiri
  • Experiences from the US | Michael Firstenberg
  • Experiences from Latin America | José Ernesto López Almaraz
  • Complex case of TTP associated with severe pancreatitis | Stephan Ziegeler
  • Cytokine release syndrome after CAR-T-Cell therapy | Gabriella Bottari
  • MDMA intoxication | Alexander Supady
  • Closing remarks | Efthymios Deliargyris
Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Rationale for the use of CytoSorb in COVID-19 patients

Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

7th International CytoSorb Users` Meeting | 2020 | Berlin

  • Welcome | Stefan Baudis & Christian Steiner
  • The Rotterdam study – long term outcome in septic shock patients | Can Ince
  • Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski
  • The International CytoSorb Registry | Frank Brunkhorst
  • The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann
  • Liver support on a higher level – what we already know | Mihai Popescu
  • The right anticoagulation – we have a lot of options | Gilda Cinnella
  • Update on drug removal – more pros than cons | Steffen Mitzner
  • Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus
  • Experiences from Italy | Giorgio Berlot
  • Experiences from Iran | Amir Ahmad Nassiri
  • Experiences from the US | Michael Firstenberg
  • Experiences from Latin America | José Ernesto López Almaraz
  • Complex case of TTP associated with severe pancreatitis | Stephan Ziegeler
  • Cytokine release syndrome after CAR-T-Cell therapy | Gabriella Bottari
  • MDMA intoxication | Alexander Supady
  • Closing remarks | Efthymios Deliargyris

More Videos

Welcome | Stefan Baudis & Christian Steiner | 7th International CytoSorb Users` Meeting | 2020
Welcome | Stefan Baudis & Christian Steiner | 7th International CytoSorb Users` Meeting | 2020
The Rotterdam study – long term outcome in septic shock patients | Can Ince | 7th IUM |  2020
The Rotterdam study – long term outcome in septic shock patients | Can Ince | 7th IUM | 2020
Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski | 7th IUM | 2020
Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski | 7th IUM | 2020
The International CytoSorb Registry | Frank Brunkhorst | 7th International CytoSorb Users` Meeting |
The International CytoSorb Registry | Frank Brunkhorst | 7th International CytoSorb Users` Meeting |
The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann | 7th IUM | 2020
The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann | 7th IUM | 2020
Liver support on a higher level – what we already know | Mihai Popescu | 7th IUM | 2020
Liver support on a higher level – what we already know | Mihai Popescu | 7th IUM | 2020
The right anticoagulation – we have a lot of options | Gilda Cinnella | 7th IUM | Berlin | 2020
The right anticoagulation – we have a lot of options | Gilda Cinnella | 7th IUM | Berlin | 2020
Update on drug removal – more pros than cons | Steffen Mitzner | 7th IUM | Berlin | 2020
Update on drug removal – more pros than cons | Steffen Mitzner | 7th IUM | Berlin | 2020
Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus | 7th IUM | Berlin | 2020
Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus | 7th IUM | Berlin | 2020
Experiences from Italy | Giorgio Berlot | 7th International CytoSorb Users` Meeting | Berlin | 2020
Experiences from Italy | Giorgio Berlot | 7th International CytoSorb Users` Meeting | Berlin | 2020